In this study, we want to learn more about the safety and effectiveness of inhaled insulin and continuous glucose monitor (CGM) use compared to usual care for people with type 1 diabetes.
Thank you for your interest, but this study is not currently enrolling.
North Carolina (Statewide)
Jamie Diner
Medicine-Endocrinology
Clinical or Medical
Interventional
Diabetes
23-1231
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
